
Weight-loss patients taking Zepbound forced to switch to Wegovy after drop in coverage
Fox News
Patients taking the GLP-1 weight loss drug Zepbound face mandatory switch to Wegovy after CVS Caremark removed the Eli Lilly medication from its preferred coverage list, citing rising costs.
"It’s been working so well for me, I’m really nervous about having to switch medications." Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.
Zepbound — along with its counterpart diabetes medication, Mounjaro — is made by Eli Lilly, while Wegovy is produced by Novo Nordisk, which also makes Ozempic.
More Related News













